• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡唑并嘧啶与五价锑对杜氏利什曼原虫和巴西利什曼原虫的协同作用。

The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.

作者信息

Martinez S, Looker D L, Berens R L, Marr J J

机构信息

Department of Medicine, University of Cauca, Popoyan, Colombia.

出版信息

Am J Trop Med Hyg. 1988 Sep;39(3):250-5. doi: 10.4269/ajtmh.1988.39.250.

DOI:10.4269/ajtmh.1988.39.250
PMID:2845824
Abstract

Pyrazolopyrimidines, particularly allopurinol, allopurinol riboside, and other purine analogues, show promise as experimental therapeutic compounds for the treatment of leishmaniasis. The combination of these agents with pentostam may produce an improved therapeutic effect. We report here on strong synergistic activity between pyrazolopyrimidines and pentavalent antimonials in a human macrophage tissue culture system infected with Leishmania donovani and L. braziliensis.

摘要

吡唑并嘧啶类化合物,特别是别嘌呤醇、别嘌呤醇核糖苷及其他嘌呤类似物,作为治疗利什曼病的实验性治疗化合物显示出前景。这些药物与喷他脒联合使用可能会产生更好的治疗效果。我们在此报告在感染杜氏利什曼原虫和巴西利什曼原虫的人巨噬细胞组织培养系统中,吡唑并嘧啶类化合物与五价锑剂之间具有强大的协同活性。

相似文献

1
The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.吡唑并嘧啶与五价锑对杜氏利什曼原虫和巴西利什曼原虫的协同作用。
Am J Trop Med Hyg. 1988 Sep;39(3):250-5. doi: 10.4269/ajtmh.1988.39.250.
2
A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.一种用于多种利什曼原虫生长的组织培养系统:生长动力学和药物敏感性
Am J Trop Med Hyg. 1988 Mar;38(2):304-7. doi: 10.4269/ajtmh.1988.38.304.
3
Primary agent for leishmaniasis.
Am J Trop Med Hyg. 1988 May;38(3):652.
4
Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.杜氏利什曼原虫无鞭毛体在人巨噬细胞系U937中的生长:药物疗效及代谢研究
J Infect Dis. 1986 Aug;154(2):323-7. doi: 10.1093/infdis/154.2.323.
5
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.五价锑对杜氏利什曼原虫体外无鞭毛体的阶段特异性活性。
Antimicrob Agents Chemother. 1999 Feb;43(2):278-82. doi: 10.1128/AAC.43.2.278.
6
Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.利什曼原虫属:通过间断性药物暴露在体外培养喷他脒抗性克隆
Exp Parasitol. 1989 Jul;69(1):78-90. doi: 10.1016/0014-4894(89)90173-2.
7
In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.甾体生物合成抑制剂及抗利什曼原虫药物组合的体外抗利什曼原虫活性
J Parasitol. 1987 Jun;73(3):671-3.
8
Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani.
Biochem Biophys Res Commun. 1988 Apr 29;152(2):605-11. doi: 10.1016/s0006-291x(88)80081-0.
9
Studies on stibanate resistant Leishmania donovani isolates of Indian origin.对源自印度的抗锑酸锑利什曼原虫分离株的研究。
Indian J Exp Biol. 2001 Mar;39(3):249-54.
10
Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.喷他脒可诱导杜氏利什曼原虫前鞭毛体和体外培养的无鞭毛体对锑和防腐剂氯甲酚产生抗性。
Antimicrob Agents Chemother. 1997 May;41(5):1064-8. doi: 10.1128/AAC.41.5.1064.

引用本文的文献

1
Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.脂质体两性霉素 B 联合别嘌醇治疗犬内脏利什曼病的疗效。
Antimicrob Agents Chemother. 2012 Jun;56(6):2858-67. doi: 10.1128/AAC.00208-12. Epub 2012 Mar 12.
2
Leishmaniases of the New World: current concepts and implications for future research.新大陆利什曼病:当前概念及对未来研究的启示
Clin Microbiol Rev. 1993 Jul;6(3):230-50. doi: 10.1128/CMR.6.3.230.
3
Use of in vitro method to assess different brands of anti-leishmanial drugs.
使用体外方法评估不同品牌的抗利什曼原虫药物。
Med Microbiol Immunol. 1991;180(1):21-7. doi: 10.1007/BF00191697.